Incidence and Predictive Factors for Positive SeHCAT Test: Improving the Diagnosis of Bile Acid Diarrhoea
Overview
Authors
Affiliations
Aims: To determine the value of SeHCAT retention in determining bile acid diarrhoea (BAD), treatment response and predictors of a positive result.
Methods: Retrospective casenote review of consecutive patients undergoing SeHCAT from 2008 to 2014, including gender, age, history, clinical, and laboratory parameters. This included diseases associated with Type 1 BAD (ileal resection, Crohn's disease) and Type 3 BAD. Chi-squared test and logistic regression determined factors predictive of BAD. Subjective response to treatment with bile acid sequestrants (BAS) was analysed with respect to the SeHCAT result.
Results: Of 387 patients, 154 (39.7%) were male and average age was 50 years. Ninety-five patients (24.5%) were investigated for Type 1 BAD, 86 (22.2%) for Type 3, and 206 patients (53.2%) for Type 2 or idiopathic BAD. There was a large increase in the number performed with time but no difference in percentage positive tests. One hundred and seventy-nine patients (46.2%) had BAD. Positive result was commonest in possible Type 1 and they had most severe BAD. Ninety-nine patients had severe BAD (<5% SeHCAT retention), 47 moderate BAD (5% to <10% retention), and 33 mild BAD (10% to <15% retention). Predictors of a positive SeHCAT were right hemicolectomy (OR 4.88), cholecystectomy (OR 2.44), and Crohn's (OR 1.86). A positive SeHCAT predicted a good or partial response to BAS of 66.7% (mild), 78.6% (moderate), or 75.9% (severe BAD).
Conclusion: SeHCAT test use increased in 2008-2014, with high positive results throughout. Ileal resection, Crohn's, and cholecystectomy independently predict BAD. SeHCAT predicted response to BAS.
Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study.
Nyboe Andersen N, Wildt S, Iversen A, Poulsen G, Jess T, Munck L BMJ Open Gastroenterol. 2024; 11(1).
PMID: 38688717 PMC: 11085898. DOI: 10.1136/bmjgast-2023-001340.
Diagnosis and treatment of post-cholecystectomy diarrhoea.
Huang R, Huang W, Xiao X, Ma L, Gu H, Yang G World J Gastrointest Surg. 2023; 15(11):2398-2405.
PMID: 38111762 PMC: 10725554. DOI: 10.4240/wjgs.v15.i11.2398.
Di Vincenzo F, Puca P, Lopetuso L, Petito V, Masi L, Bartocci B Nutrients. 2022; 14(13).
PMID: 35807844 PMC: 9268369. DOI: 10.3390/nu14132664.
Sadowski D, Camilleri M, Chey W, Leontiadis G, Marshall J, Shaffer E J Can Assoc Gastroenterol. 2020; 3(1):e10-e27.
PMID: 32010878 PMC: 6985689. DOI: 10.1093/jcag/gwz038.